They said the A1C test was new, but then said it’s already widely available. Huh?
That’s how unhelpful the ABC News story was on the proposed broader use of the A1C diabetes test.
They never once stated that this is a proposed new application of an old test – proposed by an international committee of diabetes experts.
One print story we read had no problem summarizing the news succinctly when it led:
“A blood test physicians use regularly to check blood sugar levels in people with diabetes is now being recommended as a tool to diagnose the disease.”
Was that so difficult? Would that gobble up too much precious TV airtime?
Instead, much of the airtime was wasted on meaningless people-on-the-street interviews – a hackneyed technique that doesn’t employ much in the way of sound journalism. Asking people whether they knew if they had diabetes is not directly related to the news about the expanded use of the A1C test – UNLESS those people had been tested in conventional ways and were left uncertain.
But the story also:
failed to compare the A1C with existing plasma glucose or glucose tolerance tests;
failed to describe the sensitivity or specificity of the test;
failed to describe the cost implications of this proposed broader use.
So, all in all, this story didn’t help viewer understanding very much. It just fed the “newer is better, more is better” mentality without scrutinizing – or even apparently understanding – what was before them.
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like